Unizima is an advisory services firm, focused on providing technical, strategic and workforce services for the biomanufacturing sector.
Since our inception in 2020, we have served as a trusted partner for biopharma manufacturers, governments and global health organisations to make production of biologics such as vaccines, monoclonal antibodies and insulin a sustainable reality in emerging markets.
We are driven by the end goal of delivering life-changing biologics to people who would otherwise lack access to them. We are part of Univercells and share its ground-breaking technology and engineering innovations.
